key: cord-0719937-5ek6c91s authors: Ahmed A. Ibrahim, Etedal; Isam Farah Hassan, Ramah; Abbasher Hussien Mohamed Ahmed, Khabab; Taha Salah, Elmuntasir; Eltahier Abdalla Omer, Mohammed; S. Haroun, Mazin title: Neurological manifestations of COVID‐19: A potential gate to the determinants of a poor prognosis date: 2022-04-25 journal: Brain Behav DOI: 10.1002/brb3.2587 sha: 047f80872a97e1afe7f036efaf292537cd719e12 doc_id: 719937 cord_uid: 5ek6c91s BACKGROUND: Several investigations were carried out during the pandemic, demonstrating a number of neurological symptoms linked to coronavirus disease 2019 (COVID‐19) infection. OBJECTIVES: The goal of this review is to discuss COVID‐19 disease's neurological signs and squeals. METHODOLOGY: From December 2019 to May 2020, data were retrieved from PubMed, Scopus, and ScienceDirect, as well as a manual search using Google Scholar. COVID‐19, neurological symptoms, cranial nerves, motor system were among the key phrases utilized in the search. RESULTS: The intensity of respiratory involvement increases the likelihood of neurological symptoms and consequences. According to some research, it might range from 34% to 80%. The central and peripheral neural systems are both affected, resulting in cranial nerve palsies and limb paralysis. CONCLUSION: COVID‐19 neurologic complications are key drivers of patient severity and mortality. Headache, convulsions, mental and psychic disorders, delirium, and insomnia are just some of the symptoms that the virus can cause. The olfactory nerve is the most commonly damaged cranial nerve, resulting in anosmia. Stroke (mostly infarction), encephalitis, meningitis, Guillain–Barre syndrome, relapse of multiple sclerosis, and transverse myelitis are all symptoms and squeals. Several research undertaken during the pandemic identified a variety of coronavirus disease 2019 (COVID-19)-related neurological symptoms (Wu et al., 2020) . The neurological aspects of this condition, such as mental state alterations, convulsions, febrile seizures, encephalitis, and motor impairments, have received little attention in research . It is critical to do research to document the prevalence and extent of these neurologic symptoms. The aim of this review was to discuss the neurological manifestations of COVID-19. According to a study conducted in Wuhan, China in a group of 214 COVID-19 patients, neurological manifestations are more common than expected. More than a third of the patients enrolled in the study had neurological complications . The severity of the respiratory illness increased the number of problems to nearly half of them. The authors of the same study suggested that any patient with neurologic symptoms and/or signs during the pandemic should be checked for COVID-19 to avoid delays or misdiagnosed and losing any chance to treat and prevent future transmission . Another study in France found that neurological involvement was present in 84% of cases, despite the fact that the sample size was limited, with only 84 individuals that were all gravely ill (Helms et al., 2020 The olfactory nerve is the most commonly damaged cranial nerve in COVID-19, resulting in anosmia (Lechien et al., 2020) . Some researchers believe that anosmia and loss of taste are caused by inflammation and edema that damages the olfactory cell in the olfactory groove in mice and humans, and that loss of taste (ageusia) happens as a result of anosmia. The loss of smell (anosmia) is caused by direct injury to the olfactory nerve, according to other Harvard researchers. Other cranial nerves, such as the 6th, 7th, and 8th cranial nerves, as well as the 9th, 10th, and 12th cranial nerves, may be affected, resulting in anosmia, diplopia, facial paralysis, deafness, dysphagia, and bulbar symptoms as a result of COVID-19-induced encephalitis or meningitis (Lechien et al., 2020; Liu et al., 2020) . COVID-19 may manifest as motor weakness as a symptom of neurological illnesses, such as paraplegia, which may progress to impair the abdominal muscles, upper limbs, neck, and facial nerves, resulting in quadriplegia, weak neck flexion, and bilateral facial palsy of lower motor neuron type Needham et al., 2020) . Other symptoms include weakness on one side of the body (hemiplegia), one limb (monoplegia), or all four limbs (quadriplegia) as a result of a stroke caused by arterial or venous occlusion, eventually leading to infarction or, less commonly, hemorrhage, with sites ranging from cortical, subcortical, brainstem, and venous affections (Naccarato et al., 2020; Ottaviani et al., 2020) . Because of the virus's inflammation of the spinal cord, paraplegia and quadriplegia can also occur as a result of transverse myelitis. In addition to hemiplegia induced by hemisection of the spinal cord caused by virus-driven inflammation, Brown Sequard syndrome can result in hemiplegia (Munz et al., 2020) . Furthermore, Neurological manifestations and complications of COVID-19: A literature review Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study Epidemiology of COVID-19 Neurologic features in severe SARS-CoV-2 infection Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020 Neurologic manifestations of hospitalized patients with coronavirus disease Acute transverse myelitis after COVID-19 pneumonia Has COVID-19 played an unexpected "stroke" on the chain of survival? Neurological implications of COVID-19 infections Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): A case report from an Italian COVID-hospital Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis A case report of acute transverse myelitis following novel coronavirus infection. Clinical Practice and Cases in Emergency Nervous system involvement after infection with COVID-19 and other coronaviruses The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19 Neurological manifestations of COVID-19: A potential gate to the determinants of a poor prognosis